Generic Industry Wants More Guidance On Demonstrating Equivalence Of Drug-Device Combinations
Firms want US FDA to better address how generic drug manufacturers can demonstrate similarity to innovator drug-device combination products.
Firms want US FDA to better address how generic drug manufacturers can demonstrate similarity to innovator drug-device combination products.